Amikacin pharmacokinetics in pediatric patients with malignancy.

The pharmacokinetics of amikacin were evaluated in 50 pediatric patients (1 to 17 years of age) with malignancies and normal renal function. Dosage regimens of 5 mg/kg per dose were administered intravenously (i) over 30 min every 8 h, (ii) over 60 min every 8 h, and (iii) over 60 min every 6 h. Adm...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Cleary, T G, Pickering, L K, Kramer, W G, Culbert, S, Frankel, L S, Kohl, S
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1979
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352961/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/533263/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.6.829
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!